Greenwich LifeSciences, Inc. (GLSI)

NASDAQ: GLSI · IEX Real-Time Price · USD

17.58

+0.81 (4.83%)

At close: Jul 2, 2024, 4:00 PM

17.30

-0.28 (-1.59%)

After-hours: Jul 2, 2024, 7:14 PM EDT

Greenwich LifeSciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-8.89	-7.83	-4.57	-1.86	-3.43	Upgrade
Depreciation & Amortization	0	0	0	0	0	Upgrade
Share-Based Compensation	2.38	1.74	0.66	0.68	0.19	Upgrade
Other Operating Activities	0.03	-0.12	-0.39	0.03	2.93	Upgrade
Operating Cash Flow	-6.48	-6.2	-4.29	-1.15	-0.29	Upgrade
Share Issuance / Repurchase	0	-7.54	3.11	30.17	0	Upgrade
Debt Issued / Paid	0	0	-0.28	-0.36	0.22	Upgrade
Financing Cash Flow	0	-7.54	2.84	29.81	0.22	Upgrade
Net Cash Flow	-6.48	-13.74	-1.46	28.65	-0.08	Upgrade
Free Cash Flow	-6.48	-6.2	-4.29	-1.15	-0.29	Upgrade
Free Cash Flow Per Share	-0.50	-0.48	-0.33	-0.12	-0.13	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).